Neurotrophins

Advances in Experimental Medicine and Biology

Volumn 513, Issue , 2002, Pages 303-334

  Dechant, Georg ^a   Neumann, Harald ^a,b  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b EUROPEAN NEUROSCIENCE INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR; INHIBITOR OF APOPTOSIS PROTEIN; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BODY WEIGHT DISORDER; BRAIN ISCHEMIA; CLINICAL TRIAL; DEGENERATIVE DISEASE; DEPRESSION; EATING DISORDER; EPILEPSY; HUMAN; INJECTION PAIN; MOUSE; MYALGIA; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; REVIEW; T LYMPHOCYTE;

ANIMALS; BEHAVIOR; DISEASE MODELS, ANIMAL; HUMANS; MEMORY; MODELS, MOLECULAR; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTRANSMITTER AGENTS; RECEPTORS, NERVE GROWTH FACTOR; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0036943257     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (230)

1. Gage FH. Mammalian neural stem cells. SCIENCE 2000; 287:1433-1438.
2. Barde Y-A. The Nerve Growth Factor Family. Prog Growth Factor Res 1990; 2:237-348.
3. Bibel M, Barde Y-A. Neurotrophins: Key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 2000; 14:2919-2937.
4. Thoenen H. Treatment of degenerative disorders of the nervous system: From helpless descriptive categorization to rational therapeutic approaches. In: Ingoglia NA, Murray N, eds. Axonal Regeneration in the Central Nervous System. New York: Dekker M, 2001:675-697
5. Goyal L. Cell death inhibition: keeping caspases in check. Cell 2001; 104:805-808.
6. McDonald NQ, Lapatto R, Murray-Rust J et al. New protein fold revealed by a 2.3-resolution crystal structure of nerve growth factor. Nature 1991; 354:411-414.
7. McDonald NQ, Chao MV. Structural determinants of neurotrophin action. J Biol Chem 1995; 270:19669-19672.
8. Lewin GR, Barde YA. Physiology of the Neurotrophins. Ann Rev Neurosci 1996; 19:289-317.
9. Tria MA, Fusco M, Vantini G et al. Pharmacokinetics of nerve growth factor (NGF) following different routes of administration to adult rats. Exp Neurol 1994; 127:178-183.
10. Yan Q, Matheson C, Sun J et al. Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression. Exp Neurol 1994; 127:23-36.
11. Dittrich F, Ochs G, Grosse-Wilde A et al. Pharmacokinetics of intrathecally applied BDNF and effects on spinal motoneurons. Exp Neurol 1996; 141:225-239.
12. Radziejewski C, Robinson RC. Heterodimers of the neurotrophic factors: Formation, isolation, and differential stability. Biochemistry 1993; 32:13350-13356.
13. Arakawa T, Haniu M, Narhi LO et al. Formation of heterodimers from three neurotrophins, nerve growth factor, neurotrophin-3, and brain-derived neurotrophic factor. J Biol Chem 1994; 269:27833-27839.
14. Thoenen H. Neurotrophins and activity-dependent plasticity. Prog Brain Res 2000; 128:183-191.
15. Barbacid M. The Trk family of neurotrophin receptors. J Neurobiol 1994; 25:1386-1403.
16. Grell M, Clauss M. TNF and TNF receptor superfamily. In: Bona CA, Revillard J-P, eds. Cytokines and Cytokine Receptors. New York: Harwood Academic Press, 2000:118-148.
17. Dechant G. Molecular interactions between neurotrophin receptors. Cell Tissue Res 2001; (online version http://dx.doi.org/10.1007/s004410100378)
18. Dechant G, Rodr guez-T bar A, Barde Y-A. Neurotrophin Receptors. Prog Neurobiol 1994; 42:347-352.
19. Davies AM. Neurotrophins: The yin and yang of nerve growth factor. Curr Biol 1997; 7:R38-R40.
20. Snider WD. Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell 1994; 77:627-638.
21. Holtzman DM, Li Y, Parada LF et al. p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF. Neuron 1992; 9:465-478.
22. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 1986; 6:2155-2162.
23. Klein R, Martin-Zanca D, Barbacid M et al. Expression of the tyrosine kinase receptor gene TrkB is confined to the murine embryonic and adult nervous system. Development 1990; 109:845-850.
24. Klein R, Conway D, Parada LF et al. The TrkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell 1990; 61:647-656.
25. Middlemas DS, Lindberg RA, Hunter T. trk B, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors. Mol Cell Biol 1991; 11:143-153.
26. Tessarollo L, TsoulFas P, Martin-Zanca D et al. TrkC, a receptor for neurotrophin-3, is widely expressed in the developing nervous system and in non-neuronal tissues. Development 1993; 118:463-475.
27. Barker PA. p75NTR: A study in contrasts [see comments]. Cell Death Differ 1998; 5:346-356.
28. Dobrowsky RT, Carter BD. p75 neurotrophin receptor signaling: Mechanisms for neurotrophic modulation of cell stress? J Neurosci Res 2000; 61:237-243.
29. Frade JM, Barde YA. Nerve growth factor: Two receptors, multiple functions. BioEssays 1998; 20:137-145.
30. Yamashita T, Tucker KL, Barde YA. Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron 1999; 24:585-593.
31. NTR. EMBO J 1998; 616-622.
32. Majdan M, Miller FD. Neuronal life and death decisions functional antagonism between the Trk and p75 neurotrophin receptors. Int J Dev Neurosci 1999; 17:153-161.
33. Vejsada R, Sagot Y, Kato AC. BDNF-mediated rescue of axotomized motor neurones decreases with increasing dose. NeuroReport 1994; 5:1889-1892.
34. Vejsada R, Sagot Y, Kato AC. Quantitative comparison of the transient rescue effects of neurotrophic factors on axotomized motoneurons in vivo. Eur J Neurosci 1995; 7:108-115.
35. Sommerfeld MT, Schweigreiter R, Barde YA et al. Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB. J Biol Chem 2000; 275:8982-8990.
36. ras activation in neurons by nerve growth factor and brain-derived neurotrophic factor. J Biol Chem 1995; 270:21751-21757.
37. Frank L, Ventimiglia R, Anderson K et al. BDNF down-regulates neurotrophin responsiveness, TrkB protein and TrkB mRNA levels in cultured rat hippocampal neurons. Eur J Neurosci 1996; 8:1220-1230.
38. Widmer HR, Ohsawa F, Knusel B et al. Down-regulation of phosphatidylinositol response to BDNF and NT-3 in cultures of cortical neurons. Brain Res 1993; 614:325-334.
39. Knusel B, Kaplan DR, Hefti F. Intraparenchymal NGF injections in adult and aged rats induce long- lasting Trk tyrosine phosphorylation. Exp Neurol 1996; 139:121-130.
40. Biffo S, Offenh user N, Carter BD et al. Selective binding and internalisation by truncated receptors restrict the availability of BDNF during development. Development 1995; 121:2461-2470.
41. Von Bartheld CS, Kinoshita Y, Prevette D et al. Positive and negative effects of neurotrophins on the isthmo-optic nucleus in chick embryos. Neuron 1994; 12:639-654.
42. NTR in modulating neurotrophin survival effects in developing motoneurons. Eur J Neurosci 1999; 11:1668-1676.
43. Klocker N, Cellerino A, Bahr M. Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells In vivo. J Neurosci 1998; 18:1038-1046.
44. Davies AM, Minichiello L, Klein R. Developmental changes in NT3 signalling via TrkA and TrkB in embryonic neurons. EMBO J 1995; 14:4482-4489.
45. Wyatt S, Pi n LGP, Ernfors P et al. Sympathetic neuron survival and TrkA expression in NT3-deficient mouse embryos. EMBO J 1997; 16:3115-3123.
46. Friedman WJ, Greene LA. Neurotrophin signaling via Trks and p75. Exp Cell Res 1999; 253:131-142.
47. Yuen EC, Mobley WC. Early BDNF, NT-3, and NT-4 signaling events. Exp Neurol 1999; 159:297-308.
48. Cunningham ME, Greene LA. A function-structure model for NGF-activated TRK. EMBO Journal 1998; 17:7282-7293.
49. Kaplan DR, Miller FD. Signal transduction by the neurotrophin receptors. Curr Op Cell Biol 1997; 9:213-221.
50. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 1999; 13:2905-2927.
51. Holgado-Madruga M, Moscatello DK, Emlet DR et al. Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proc Natl Acad Sci USA 1997; 94:12419-12424.
52. Yamada M, Ohnishi H, Sano S et al. Insulin receptor substrate (IRS)-1 and IRS-2 are tyrosine-phosphorylated and associated with phosphatidylinositol 3-kinase in response to brain-derived neurotrophic factor in cultured cerebral cortical neurons. J Biol Chem 1997; 272:30334-30339.
53. Canossa M, Gartner A, Campana G et al. Regulated secretion of neurotrophins by metabotropic glutamate group I (mGluR1) and Trk receptor activation is mediated via phospholipase C signalling pathways. EMBO J 2001; 20:1640-1650.
54. Maderdrut JL, Oppenheim RW, Prevette D. Enhancement of naturally occurring cell death in the sympathetic and parasympathetic ganglia of the chicken embryo following blockade of ganglionic transmission. Brain Res 1988; 444:189-194.
55. Ghosh A, Carnahan J, Greenberg ME. Requirement for BDNF in activity-dependent survival of cortical neurons. SCIENCE 1994; 263:1618-1623.
56. McAllister AK, Katz LC, Lo DC. Neurotrophin regulation of cortical dendritic growth requires activity. Neuron 1996; 17:1057-1064.
57. Brodski C, Schn rch H, Dechant G. Neurotrophin-3 promotes the cholinergic differentiation of sympathetic neurons. Proc Natl Acad of Sci USA 2000; 97:9683-9688.
58. NTR with Trk receptors. J Biol Chem 1995; 270:22135-22142.
59. Dobrowsky RT, Carter BD. Coupling of the p75 neurotrophin receptor to sphingolipid signaling. Ann NY Acad Sci 1998; 845:32-45.
60. Carter BD, Kaltschmidt C, Kaltschmidt B et al. Selective activation of NF-kappaB by nerve growth factor through the neurotrephin receptor p75. Science 1996; 272:542-545.
61. Hamanoue M, Middleton G, Wyatt S et al. p7S-mediated NF-kappaB activation enhances the survival response of developing sensory neurons to nerve growth factor. Mol Cell Neurosci 1999; 14:28-40.
62. + neuroblasts exhibit differential neurotrophin responsiveness during sympathetic development. Dev Biol 2000; 218:367-377.
63. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT et al. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 1996; 383:716-719.
64. Frade JM, Rodr guez-T bar A, Barde YA. Induction of cell death by endogenous nerve growtla factor through its p75 receptor. Nature 1996; 383:166-168.
65. Agerman K, Baudet C, Fundin B et al. Attenuation of a caspase-3 dependent cell death in NT4- and p75-deficient embryonic sensory neurons. Mol Cell Neurosci 2000; 16:258-268.
66. Yoon SO, Casaccia-Bonnefil P, Carter B et al. Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J Neurosci 1998; 18:3273-3281.
67. Aloyz RS, Bamji SX, Pozniak CD et al. P53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J Cell Biol 1998; 143:1691-1703.
68. Pozniak CD, Radinovic S, Yang A et al. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. SCIENCE 2000; 289:304-306.
69. Budd SL, Nicholls DG. Mitochondria in the life and death of neurons. Essays Biochem 1998; 33:43-52.
70. Martin LJ. Neuronal cell death in nervous system development, disease, and injury. Int J Mol Med 2001; 7:455-478.
71. Dugan LL, Creedon DJ, Johnson EM, Jr. et al. Rapid suppression of free radical formation by nerve growth factor involves the mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 1997; 94:4086-4091.
72. Koh JY, Gwag BJ, Lobner D et al. Potentiated necrosis of cultured cortical neurons by neurotrophins. Science 1995; 268:573-575.
73. Davies AM. The Bcl-2 family of proteins, and the regulation of neuronal survival. Trends Neurosci 1995; 18:355-358.
74. Martin LJ. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism. J Neuropathol Exp Neurol 1999; 58:459-471.
75. Lindholm D. Role of neurotrophins in preventing glutamate induced neuronal cell death. J Neurol 1994; 242:S16-S18.
76. Sagot Y, Dubois-Dauphin M, Tan SA et al. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J Neurosci 1995; 15:7727-7733.
77. Patel TD, Jackman A, Rice FL et al. Development of sensory neurons in the absence of NGF/TrkA signaling in vivo. Neuron 2000; 25:345-357.
78. McAllister AK, Katz LC, Lo DC. Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth. Neuron 1997; 18:767-778.
79. Leing rtner A, Heisenberg C-P, Kolbeck R et al. Brain-derived neurotrophic factor increases neurotrophin- 3 expression in cerebellar granule neurons. J Biol Chem 1994; 269:828-830.
80. Canossa M, Griesbeck O, Berninger B et al. Neurotrophin release by neurotrophins: Implications for activity- dependent neuronal plasticity. Proc Natl Acad Sci USA 1997; 94:13279-13286.
81. Kr ttgen A, Mller JC, Heymach JV, Jr. et al. Neurotrophins induce release of neurotrophins by the regulated secretory pathway. Proc Natl Acad Sci USA 1998; 95:9614-9619.
82. Causing CG, Gloster A, Aloyz R et al. Synaptic innervation density is regulated by neuron-derived BDNF. Neuron 1997; 18:257-267.
83. Giehl KM. Trophic dependencies of rodent corticospinal neurons. Rev Neurosci 2001; 12:79-94.
84. Merlio JP, Ernfors P, Kokaia Z et al. Increased production of the TrkB protein tyrosine kinase receptor after brain insults. Neuron 1993; 10:151-164.
85. Kokaia Z, Andsberg G, Yah Q et al. Rapid alterations of BDNF protein levels in the rat brain after focal ischemia: Evidence for increased synthesis and anterograde axonal transport. Exp Neurol 1998; 154:289-301.
86. Beck T, Lindholm D, Castren E et al. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J Cereb Blood Flow Metab 1994; 14:689-692.
87. Tsukahara T, Yonekawa Y, Tanaka K et al. The role of brain-derived neurotrophic factor in transient forebrain ischemia in the rat brain. Neurosurgery 1994; 34:323-331.
88. Chan KM, Lam DT, Pong K et al. Neurotrophin-4/5 treatment reduces infarct size in rats with middle cerebral artery occlusion. Neurochem Res 1996; 21:763-767.
89. Gall C, Lauterborn J, Bundman M et al. Seizures and the regulation of neurotrophic factor and neuropeptide gene expression in brain. Epilepsy Res Suppl 1991; 4:225-245.
90. Ernfors P, Bengzon J, Kokaia Z et al. Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron 1991; 7:165-176.
91. Mudo G, Jiang XH, timmusk t et al. Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine. Epilepsia 1996; 37:198-207.
92. Binder DK, Routbort MJ, Ryan TE et al. Selective inhibition of kindling development by intraventricular administration of TrkB receptor body. J Neurosci 1999; 19:1424-1436.
93. Giehl KM, Tetzlaff W. BDNF and NT-3, but not NGF, prevent axotomy-inducod death of rat corticospinal neurons in vivo. Eur J Neurosci 1996; 8:1167-1175.
94. Schnell L, Schneider R, Kolbeck R et al. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature 1994; 367:170-173.
95. Hefti F, Weiner WJ. Nerve growth factor and Alzheimer s disease. Ann Neurol 1986; 20:275-281.
96. Vazquez ME, Ebendal T. Messenger RNAs for trk and the low-affinity NGF receptor in rat basal forebrain. NeuroReport 1991; 2:593-596.
97. Venero JL, Hefti F. TrkA NGF receptor expression by non-cholinergic thalamic neurons. NeuroReport 1993; 4:959-962.
98. Hefti F, Lapchak PA. Pharmacology of nerve growth factor in the brain. Adv Pharmacol 1993; 24:239-273.
99. Will B, Hefti F. Behavioural and neurochemical effects of chronic intraventricular injections of nerve growth factor in adult rats with fimbria lesions. Behav Brain Res 1985; 17:17-24.
100. Fischer W, Wictorin K, Bjoerklund A et al. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 1987; 329:65-68.
101. Markowska AL, Koliatsos VE, Breckler SJ et al. Human nerve growth factor improves spatial memory in aged but not in young rats. J Neurosci 1994; 14:4815-4824.
102. Widmer HR, Knusel B, Hefti F. BDNF protection of basal forebrain cholinergic neurons after axotomy: complete protection of p75NGFR-positive cells. NeuroReport 1993; 4:363-366.
103. Koliatsos VE, Price DL, Gouras GK et al. Highly selective effects of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons. J Comp Neurol 1994; 343:247-262.
104. Fischer W, Sirevaag A, Wiegand SJ et al. Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor. Proc Natl Acad Sci USA 1994; 91:8607-8611.
105. Kn sel B, Winslow JW, Rosenthal A et al. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci USA 1991; 88:961-965.
106. Alderson RF, Wiegand SJ, Anderson KD et al. Neurotrophin-4/5 maintains the cholinergic phenotype of axotomized septal neurons. Eur J Neurosci 1996; 8:282-290.
107. Phillips HS, Hains JM, Armanini M et al. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer s disease. Neuron 1991; 7:695-702.
108. Peterson DA, Leppert JT, Lee KF et al. Basal forebrain neuronal loss in mice lacking neurotrophin receptor p75. Science 1997; 277:837-838.
109. Hagg T, Van der Zee CEEM, Ross GM et al. Basal forebrain neuronal loss in mice lacking neurotrophin receptor p75 Response. Science 1997; 277:838-839.
110. Olson L, Nordberg A, von Hoist H et al. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm Park Dis Dement Sect 1992; 4:79-95.
111. Eriksdotter JM, Nordberg A, Amberla K et al. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer s disease. Dement Geriatr Cogn Disord 1998; 9:246-257.
112. Hyman C, Hofer M, Barde Y-A et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991; 350:230-232.
113. Spina MB, Squinto SP, Miller J et al. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system. J Neurochem 1992; 59:99-106.
114. Knusel B, Beck KD, Winslow JW et al. Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci 1992; 12:4391-4402.
115. Hagg T. Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo. Exp Neurol 1998; 149:183-192.
116. Altar CA, Boylan CB, Jackson C et al. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc Natl Acad Sci USA 1992; 89:11347-11351.
117. Lapchak PA, Beck KD, Araujo DM et al. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection. Neuroscience 1993; 53:639-650.
118. Ringstedt T, Lagercrantz H, Persson H. Expression of members of the trk family in the developing postnatal rat brain. Dev Brain Res 1993; 72:119-131.
119. Numan S, Seroogy KB. Expression of TrkB and TrkC mRNAs by adult midbrain dopamine neurons: A double-label in situ hybridization study. J Comp Neurol 1999; 403:295-308.
120. Koliatsos VE, Clatterbuck RE, Winslow JW et al. Evidence that brain-derived neurotrophic factor is atrophic factor for motor neurons in vivo. Neuron 1993; 10:359-367.
121. Klein R, Smeyne RJ, Wurst W et al. Targeted disruption of the TrkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 1993; 75:113-122.
122. Liu X, Ernfors P, Wu H et al. Sensory but not motor neuron deficits in mice lacking NT4 and BDNF. Nature 1995; 375:238-241.
123. Conover JC, Erickson JT, Katz DM et al. Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4. Nature 1995; 375:235-238.
124. Kobayashi NR, Bedard AM, Hincke MT et al. Increased expression of BDNF and TrkB mRNA in rat facial motoneurons after axotomy. Eur J Neurosci 1996; 8:1018-1029.
125. Sendtner M, Holtmann B, Hughes RA. The response of motoneurons to neurotrophins. Neurochem Res 1996; 21:831-841.
126. Sendtner M, Holtmann B, Kolbeck R et al. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 1992; 360:757-759.
127. Yah Q, Elliott J, Snider WD. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 1992; 360:753-755.
128. Johnson JE, Qin-Wei Y, Prevette D et al. Brain-derived proteins that rescue spinal motoneurons from cell death in the chick embryo: Comparisons with target- derived and recombinant factors. J Neurobiol 1995; 27:573-589.
129. Yah Q, Matheson C, Lopez OT et al. The biological responses of axotomized adult motoneurons to brain- derived neurotrophic factor. J Neurosci 1994; 14:5281-5291.
130. Ernfors P, Henschen A, Olson L et al. Expression of nerve growth factor receptor mRNA is developmentally regulated and increased after axotomy in rat spinal cord motoneurons. Neuron 1989; 2:1605-1613.
131. Koliatsos VE, Crawford TO, Price DL. Axotomy induces nerve growth factor receptor immunoreactivity in spinal motor neurons. Brain Res 1991; 549:297-304.
132. Frade JM, Barde YA. Genetic evidence for cell death mediated by nerve growth factor and the neurotrophin receptor p75 in the developing mouse retina and spinal cord. Development 1999; 126:683-690.
133. Ferri CC, Moore FA, Bisby MA. Effects of facial nerve injury on mouse motoneurons lacking the p75 low-affinity neurotrophin receptor. Journal of Neurobiology 1998; 34:1-9.
134. Yan Q, Miller JA. The use of trophic factors in degenerative motoneuron diseases. Exp Neurol 1993; 124:60-63.
135. Stoeckel K, Guroff G, Schwab M et al. The significance of retrograde axonal transport for the accumulation of systemically administered nerve growth factor (NGF) in the rat superior cervical ganglion. Brain Res 1976; 109:271-284.
136. Curtis R, Tonra JR, Stark JL et al. Neuronal injury increases retrograde axonal transport of the neurotrophins to spinal sensory neurons and motor neurons via multiple receptor mechanisms. Mol Cell Neurosci 1998; 12:105-118.
137. Ochs G, Penn RD, Giess R et al. A trial of recombinant methionyl human Brain-Derived Neurotrophic Factor (BDNF) given by intrathecal (IT) infusion to patients with Amyotrophic Lateral Sclerosis (ALS). Neurology 1998; A246.
138. Phillips HS, Armanini MP. Expression of the trk family of neurotrophin receptors in developing and adult dorsal root ganglion neurons. Philos Trans R Soc Lond B Biol Sci 1996; 351:413-416.
139. Karchewski LA, Kim FA, Johnston J et al. Anatomical evidence supporting the potential for modulation by multiple neurotrophins in the majority of adult lumbar sensory neurons. J Comp Neurol 1999; 413:327-341.
140. Lindsay RM. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J Neurosci 1988; 8:2394-2405.
141. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989; 337:362-364.
142. Mendell LM. Neurotrophin action on sensory neurons in adults: an extension of the neurotrophic hypothesis. Pain 1999; Suppl 6:S127-S132.
143. Verge VM, Gratto KA, Karchewski LA et al. Neurotrophins and nerve injury in the adult. Philos Trans R Soc Lond B Biol Sci 1996; 351:423-430.
144. Anand P. Neurotrophins and peripheral neuropathy. Philos Trans R Soc Lond B Biol Sci 1996; 351:449-454.
145. Lewin GR. Neurotrophins and the specification o neuronal phenotype. Phil Trans R Soc London 1996;405-411.
146. Gao WQ, Dybdal N, Shinsky N et al. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann Neurol 1995; 38:30-37.
147. Apfel SC, Arezzo JC, Lipson L et al. Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 1992; 31:76-80.
148. Ernfors P, Van De WT, Loring J et al. Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 1995; 14:1153-1164.
149. Ernfors P, Duan ML, Elshamy WM et al. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat Med 1996; 2:463-467.
150. Staecker H, Kopke R, Malgrange B et al. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. NeuroReport 1996; 7:889-894.
151. Chalazonitis A, Rothman TP, Chen J et al. Neurotrophin-3 induces neural crest-derived cells from fetal rat gut to develop in vitro as neurons or gila. J Neurosci 1994; 14:6571-6584.
152. Sternini C, Su D, Arakawa J et al. Cellular localization of Pan-trk immunoreactivity and TrkC mRNA in the enteric nervous system. J Comp Neurol 1996; 368:597-607.
153. McArthur JC, Yiannoutsos C, Simpson DM et al. A phase II thai of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology 2000; 54:1080-1088.
154. Apfel SC, Kessler JA, Adomato BT et al. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology 1998; 51:695-702.
155. Apfel SC, Schwartz S, Adornato BT et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 2000; 284:2215-2221.
156. Petty BG, Cornblath DR, Adornato BT et al. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 1994; 36:244-246.
157. Mazurek N, Weskamp G, Erne P et al. Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS Lett 1986; 198:315-320.
158. Chuang H, Prescott ED, Kong H et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001; 411:957-962.
159. Lambiase A, Rama P, Bonini S et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998; 338:1174-1180.
160. Tuveri M, Generini S, Matucci-Cerinic M et al. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 2000; 356:1739-1740.
161. Siuciak JA, Clark MS, Rind HB et al. BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain. J Neurosci Res 1998; 52:149-158.
162. A serotonin receptor and TrkB induces the serotonergic neuronal phenotype. Mol Cell Neurosci 2000; 15:446-455.
163. Arenas E, Persson H. Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature 1994; 367:368-371.
164. Pelleymounter MA, Cullen MJ, Wellman CL. Characteristics of BDNF-induced weight loss. Exp Neurol 1995; 131:229-238.
165. Mamounas LA, Altar CA, Blue ME et al. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 2000; 20:771-782.
166. Shen RY, Altar CA, Chiodo LA. Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo. Proc Natl Acad Sci USA 1994; 91:8920-8924.
167. Celada P, Siuciak JA, Tran TM et al. Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphe serotonergic neurons. Brain Res 1996; 712:293-298.
168. Martin-Iverson MT, Todd KG, Altar CA. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: Interactions With amphetamine. J Neurosci 1994; 14:1262-1270.
169. Lyons WE, Mamounas LA, Ricaurte GA et al. Brain-derived neurotropbic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 1999; 96:15239-15244.
170. Kernie SG, Liebl DJ, Parada LF. BDNF regulates eating behavior and locomotor activity in mice. EMBO J 2000; 19:1290-1300.
171. Kafitz KW, Rose CR, Thoenen H et al. Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 1999; 401:918-921.
172. Lohof AM, Ip NY, Poo M. Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 1993; 363:350-353.
173. Jovanovic JN, Czernik AJ, Fienberg AA et al. Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat Neurosci 2000; 3:323-329.
174. Ruit KG, Osborne PA, Schmidt RE et al. Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse. J Neurosci 1990; 10:2412-2419.
175. McAllister AK, Lo DC, Katz LC. Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 1995; 15:791-803.
176. Korte M, Carroll P, Wolf E et al. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 1995; 92:8856-8860.
177. Minichiello L, Korte M, Wolfer D et al. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 1999; 24:401-414.
178. Duman RS, Vaidya VA, Nibuya M et al. Stress, antidepressant treatments, and neurotrophic factors: Molecular and cellular mechanisms. The Neuroscientist 1995; 6:351-360.
179. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psych 1997; 54:597-606.
180. Siuciak JA, Lewis DR, Wiegand SJ et al. Antidepressant-like effect of brain-derived neurotropbic factor (BDNF). Pharmacol Biochem Behav 1997; 56:131-137.
181. Marty S, Berzaghi MD, berninger b. Neurotrophins and activity-dependent plasticity of cortical interneurons. Trends Neurosci 1997; 20:198-202.
182. Adams B, Sazgar M, Osebobo P et al. Nerve growth factor accelerates seizure development, enhances mossy fiber sprouting, and attenuates seizure-induced decreases in neuronal density in the kindling model of epilepsy. J Neurosci 1997; 17:5288-5296.
183. Van der Ze CE, Rashid K, Le K et al. Intraventricular administration of antibodies to nerve growth factor retards kindling and blocks mossy fiber sprouting in adult rats. J Neurosci 1995; 15: 5316-5323.
184. Reibel S, Larmet Y, Le BT et al. Brain-derived neurotrophic factor delays hippocampal kindling in the rat. Neuroscience 2000; 100:777-788.
185. Anton ES, Weskamp G, Reichardt LF et al. Nerve growth factor and its low-affinity receptor promote Schwann cell migration. Proc Natl Acad Sci USA 1994; 91:2795-2799.
186. Winkler J, Ramirez GA, Kuhn HG et al. Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor. Ann Neurol 1997; 41:82-93.
187. Barres BA, Raff MC, Gaese F et al. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 1994; 367:371-375.
188. McTigue DM, Horner PJ, Stokes BT et al. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 1998; 18:5354-5365.
189. Syroid DE, Maycox PJ, Soilu-Hanninen M et al. Induction of postnatal schwann cell death by the low-affinity neurotrophin receptor in vitro and after axotomy. J Neurosci 2000; 20:5741-5747.
190. Torcia M, Bracci-Laudiero L, Lucibello M et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996; 85:345-356.
191. Kimata H, Yoshida A, Ishioka C et al. Nerve growth factor specifically induces human IgG4 production. Eur J Immunol 1991; 21:137-141.
192. Neumann H, Misgeld T, Matsumuro K et al. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc Natl Acad Sci USA 1998; 95:5779-5784.
193. Flugel A, Matsumuro K, Neumann H et al. Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendothelial migration. Eur J Immunol 2001; 31:11-22.
194. Villoslada P, Hauser SL, Bartke I et al. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med 2000; 191:1799-1806.
195. Donovan MJ, Lin MI, Wiegn P et al. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 2000; 127:4531-4540.
196. Donovan MJ, Hahn R, Tessarollo L et al. Identification of an essential nonneuronal function of neurotrophin 3 in mammalian cardiac development. Nat Genetics 1996; 14:210-213.
197. Donovan MJ, Miranda RC, Kraemer R et al. Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol 1995; 147:309-324.
198. Ilag LL, Curtis R, Glass D et al. Pan-neurotrophin 1: a genetically engineered neurotrophic factor displaying multiple specificities in peripheral neurons in vitro and in vivo. Proc Natl Acad Sci USA 1995; 92:607-611.
199. Urfer R, TsoulFas P, Soppet D et al. The binding epitopes of neurotrophin-3 to its receptors TrkC and gp75 and the design of a multifunctional human neurotrophin. EMBO J 1994; 13:5896-5909.
200. Friedman WJ, Black IB, Persson H et al. Synergistic trophic actions on rat basal forebrain neurons revealed by a synthetic NGF/BDNF chimaeric molecule. Eur J Neurosci 1995; 7:656-662.
201. Ryden M, Murray-Rust J, Glass D et al. Functional analysis of mutant neurotrophins deficient in low-affinity binding reveals a role for p75LNGFR in NT-4 signalling. EMBO J 1995; 14:1979-1990.
202. Saragovi HU, Gehring K. Development of pharmacological agents for targeting neurotrophins and their receptors. Trends Pharmacol Sci 2000; 21:93-98.
203. LeSauteur L, Maliartchouk S, Le Jeune H et al. Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody. J Neurosci 1996; 16:1308-1316.
204. Maliartchouk S, Feng Y, Ivanisevic L et al. A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors. Mol Pharmacol 2000; 57:385-391.
205. Treanor JJS, Schmelzer C, Knusel B et al. Heterodimeric neurotrophins induce phosphorylation of Trk receptors and promote neuronal differentiation in PC12 cells. J Biol Chem 1995; 270:23104-23110.
206. Friden PM, Walus LR, Watson P et al. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 1993; 259:373-377.
207. Hefti F. Pharmacology of neurotrophic factors. Annu Rev Pharmacol Toxicol 1997; 37:239-267.
208. Saudou F, Finkbeiner S, Devys D et al. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 1998; 95:55-66.
209. Shieh PB, Ghosh A. Molecular mechanisms underlying activity-dependent regulation of BDNF expression. J Neurobiol 1999; 41:127-134.
210. timmusk t, Palm K, Metsis M et al. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 1993; 10:475-489.
211. Ma L, Merenmies J, Parada LF. Molecular characterization of the TrkA/NGF receptor minimal enhancer reveals regulation by multiple cis elements to drive embryonic neuron expression. Development 2000; 127:3777-3788.
212. Pan W, Banks WA, Kastin AJ. Permeability of the blood-brain barrier to neurotrophins. Brain Res 1998; 788:87-94.
213. Gravel C, Gotz R, Lorrain A et al. Adenoviral gene transfer of ciliary neurotrophic factor and brain- derived neurotrophic factor leads to long-term survival of axotomized motor neurons. Nat Med 1997; 3:765-770.
214. Mandel RJ, Gage FH, Clevenger DG et al. Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration. Exp Neurol 1999; 155:59-64.
215. Kordower JH, Emborg ME, Bloch J et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson s disease. Science 2000; 290:767-773.
216. Flugel A, Willem M, Berkowicz T et al. Gene transfer into CD4+ T lymphocytes: Green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nat Med 1999; 5:843-847.
217. Hoffman D, Wahlberg L, Aebischer P. NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion. Exp Neurol 1990; 110:39-44.
218. Shibayama M, Hattori S, Himes BT et al. Neurotrophin-3 prevents death of axotomized Clarke s nucleus neurons in adult rat. J Comp Neurol 1998; 390:102-111.
219. Hoffman D, Breakefield XO, Short MP et al. Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. Exp Neurol 1993; 122:100-106.
220. Winn SR, Hammang JP, Emerich DF et al. Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc Natl Acad Sci USA 1994; 91:2324-2328.
221. Haase G, Kennel P, Pettmann B et al. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat Med 1997; 3:429-436.
222. Sendtner M. Gene therapy for motor neuron disease. Nat Med 1997; 3:380-381.
223. Sagot Y, Rosse T, Vejsada R et al. Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease. J Neurosci 1998; 18:1132-1141.
224. Nagatsu T, Mogi M, Ichinose H et al. Changes in cytokines and neurotrophins in Parkinson s disease. J Neural Transm Suppl 2000;277-290.
225. Vicario-Abejon C, Johe KK, Hazel TG et al. Functions of basic fibroblast growth factor and neurotrophins in the differentiation of hippocampal neurons. Neuron 1995; 15:105-114.
226. Vicario-Abejon C, Collin C, TsoulFas P et al. Hippocampal stem cells differentiate into excitatory and inhibitory neurons. Eur J Neurosci 2000; 12:677-688.
227. Leventhal C, Rafii S, Rafii D et al. Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma. Mol Cell Neurosci 1999; 13:450-464.
228. Rubio F, Kokaia Z, Arco A et al. BDNF gene transfer to the mammalian brain using CNS-derived neural precursors. Gene Ther 1999; 6:1851-1866.
229. Martinez-Serrano A, Lundberg C, Horellou P et al. CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: Complete rescue of axotomized cholinergic neurons after transplantation into the septum. J Neurosci 1995; 15:5668-5680.
230. Moutsatsos IK, Turgeman G, Zhou S et al. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 2001; 3:449-461.